Health
Efficacy and safety of an RBD-based recombinant protein COVID-19 vaccine – News-Medical.net
A study developed a protein-based subunit vaccine, PHH-1V, that consisted of a recombinant RBD fusion heterodimer of the alpha)…
The emergence of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led the scientific community and pharmaceutical industry to focus on the development of vaccines to combat the health…
Continue Reading
-
Business19 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General19 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General18 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting
-
General21 hours agoPutin says US-Ukraine text could form basis for future peace agreement